The Dysfunctional MDM2–p53 Axis in Adipocytes Contributes to Aging-Related Metabolic Complications by Induction of Lipodystrophy
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Profound loss and senescence of adipose tissues are hallmarks of advanced age, but the underlying cause and their metabolic consequences remain obscure. Proper function of the murine double minute 2 (MDM2)–p53 axis is known to prevent tumorigenesis and several metabolic diseases, yet its role in regulation of adipose tissue aging is still poorly understood. In this study, we show that the proximal p53 inhibitor MDM2 is markedly downregulated in subcutaneous white and brown adipose tissues of mice during aging. Genetic disruption of MDM2 in adipocytes triggers canonical p53-mediated apoptotic and senescent programs, leading to age-dependent lipodystrophy and its associated metabolic disorders, including type 2 diabetes, nonalcoholic fatty liver disease, hyperlipidemia, and energy imbalance. Surprisingly, this lipodystrophy mouse model also displays premature loss of physiological integrity, including impaired exercise capacity, multiple organ senescence, and shorter life span. Transplantation of subcutaneous fat rejuvenates the metabolic health of this aging-like lipodystrophy mouse model. Furthermore, senescence-associated secretory factors from MDM2-null adipocytes impede adipocyte progenitor differentiation via a non–cell-autonomous manner. Our findings suggest that tight regulation of the MDM2–p53 axis in adipocytes is required for adipose tissue dynamics and metabolic health during the aging process.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670
Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice
Chang, J., Wang, Y., Shao, L., Laberge, R.-M., Demaria, M., Campisi, J., Janakiraman, K., Sharpless, N. E., Ding, S., Feng, W., et al. (2016) · Nature Medicine · doi:10.1038/nm.4010 · Cited by 1,819 · cited 1×
“These data also indicate that removal of not only senescent adipocyte progenitors but also senescent and apoptotic adipocytes is essential to rejuvenate adipose tissue function in aging (26,40).”
Backgroundp53 mutant mice that display early ageing-associated phenotypes
Tyner, S. D., Venkatachalam, S., Choi, J., Jones, S., Ghebranious, N., Igelmann, H., Lu, X., Soron, G., Cooper, B., Brayton, C., et al. (2002) · Nature · doi:10.1038/415045a · Cited by 1,459 · cited 2×
“Expression of the active form of p53, which lacks of MDM2-binding domain, reduces life span (9).”
BackgroundAMPK and PPARδ Agonists Are Exercise Mimetics
Narkar, V. A., Downes, M., Yu, R. T., Embler, E., Wang, Y.-X., Banayo, E., Mihaylova, M. M., Nelson, M. C., Zou, Y., Juguilon, H., et al. (2008) · Cell · doi:10.1016/j.cell.2008.06.051 · Cited by 1,222
Fat tissue, aging, and cellular senescence
Tchkonia, T., Morbeck, D. E., Von Zglinicki, T., Van Deursen, J., Lustgarten, J., Scrable, H., Khosla, S., Jensen, M. D., & Kirkland, J. L. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00608.x · Cited by 1,094 · cited 4×
“growth factors, matrix metalloproteinases, and metabolites (1,33).”
BackgroundInfluentialMarino, S., Vooijs, M., van der Gulden, H., Jonkers, J., & Berns, A. (2000) · Genes & Development · doi:10.1101/gad.14.8.994 · Cited by 920
Xu, M., Tchkonia, T., Ding, H., Ogrodnik, M., Lubbers, E. R., Pirtskhalava, T., White, T. A., Johnson, K. O., Stout, M. B., Mezera, V., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1515386112 · Cited by 915 · cited 1×
“Removal of senescent cells in adipose tissue delays the fat loss and its related metabolic dysfunctions in the aging mouse models (6,7).”
BackgroundAge-related changes in total and regional fat distribution
Kuk, J. L., Saunders, T. J., Davidson, L. E., & Ross, R. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2009.06.001 · Cited by 778 · cited 2×
“The age of onset of aging-specific reduction of adipose tissue (lipodystrophy) varies across different ethnic groups (2).”
BackgroundBubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice
Baker, D. J., Jeganathan, K. B., Cameron, J. D., Thompson, M., Juneja, S., Kopecka, A., Kumar, R., Jenkins, R. B., de Groen, P. C., Roche, P., et al. (2004) · Nature Genetics · doi:10.1038/ng1382 · Cited by 731 · cited 1×
“Several premature ageing mouse models suffer from a dramatic loss of sWAT (8-10).”
BackgroundTargeting senescent cells enhances adipogenesis and metabolic function in old age
Xu, M., Palmer, A. K., Ding, H., Weivoda, M. M., Pirtskhalava, T., White, T. A., Sepe, A., Johnson, K. O., Stout, M. B., Giorgadze, N., et al. (2015) · eLife · doi:10.7554/elife.12997 · Cited by 604 · cited 4×
“These data also indicate that removal of not only senescent adipocyte progenitors but also senescent and apoptotic adipocytes is essential to rejuvenate adipose tissue function in aging (26,40).”
BackgroundResultInfluentialModulation of mammalian life span by the short isoform of p53
Maier, B., Gluba, W., Bernier, B., Turner, T., Mohammad, K., Guise, T., Sutherland, A., Thorner, M., & Scrable, H. (2004) · Genes & Development · doi:10.1101/gad.1162404 · Cited by 586
Pajvani, U. B., Trujillo, M. E., Combs, T. P., Iyengar, P., Jelicks, L., Roth, K. A., Kitsis, R. N., & Scherer, P. E. (2005) · Nature Medicine · doi:10.1038/nm1262 · Cited by 322
Pathology of mouse models of accelerated aging
Harkema, L., Youssef, S. A., & de Bruin, A. (2016) · Veterinary Pathology · doi:10.1177/0300985815625169 · Cited by 105 · cited 1×
“Like the accelerated aging mouse models (10), this lipodystrophy mouse exhibited numerous metabolic deficits, reduced exercise capacity, multiorgan senescence, and shorter life span.”
BackgroundAblation of XP-V gene causes adipose tissue senescence and metabolic abnormalities
Chen, Y.-W., Harris, R. A., Hatahet, Z., & Chou, K.-M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1506954112 · Cited by 86
Research works printed but not linked: 28
- Guillermier, 2017, Imaging mass spectrometry demonstrates age-related decline in human adipose plasticity, JCI Insight, 2, e90349, 10.1172/jci.insight.90349 · DOI
- Yoneshiro, 2011, Age-related decrease in cold-activated brown adipose tissue and accumulation of body fat in healthy humans, Obesity (Silver Spring), 19, 1755, 10.1038/oby.2011.125 · DOI · Paper page
- Findeisen, 2011, Oxidative stress accumulates in adipose tissue during aging and inhibits adipogenesis, PLoS One, 6, e18532, 10.1371/journal.pone.0018532 · DOI
- Wu, 2018, Relevance of the p53-MDM2 axis to aging, Cell Death Differ, 25, 169, 10.1038/cdd.2017.187 · DOI · Paper page
- Berkers, 2013, Metabolic regulation by p53 family members, Cell Metab, 18, 617, 10.1016/j.cmet.2013.06.019 · DOI · Paper page
- Li, 2016, The MDM2-p53-pyruvate carboxylase signalling axis couples mitochondrial metabolism to glucose-stimulated insulin secretion in pancreatic β-cells, Nat Commun, 7, 11740, 10.1038/ncomms11740 · DOI
- Grier, 2002, Conditional allele of mdm2 which encodes a p53 inhibitor, Genesis, 32, 145, 10.1002/gene.10066 · DOI
- Eguchi, 2011, Transcriptional control of adipose lipid handling by IRF4, Cell Metab, 13, 249, 10.1016/j.cmet.2011.02.005 · DOI · Paper page
- Luk, 2017, FAK signalling controls insulin sensitivity through regulation of adipocyte survival, Nat Commun, 8, 14360, 10.1038/ncomms14360 · DOI
- Kwok, 2016, Adipose-specific inactivation of JNK alleviates atherosclerosis in apoE-deficient mice, Clin Sci (Lond), 130, 2087, 10.1042/CS20160465 · DOI
- Shu, 2017, A-FABP mediates adaptive thermogenesis by promoting intracellular activation of thyroid hormones in brown adipocytes, Nat Commun, 8, 14147, 10.1038/ncomms14147 · DOI · Paper page
- Cheng, 2012, APPL1 potentiates insulin secretion in pancreatic β cells by enhancing protein kinase Akt-dependent expression of SNARE proteins in mice, Proc Natl Acad Sci U S A, 109, 8919, 10.1073/pnas.1202435109 · DOI
- Wang, 2018, Activation of hypothalamic RIP-Cre neurons promotes beiging of WAT via sympathetic nervous system, EMBO Rep, 19, e44977, 10.15252/embr.201744977 · DOI
- Rufini, 2013, Senescence and aging: the critical roles of p53, Oncogene, 32, 5129, 10.1038/onc.2012.640 · DOI · Paper page
- Zhang, 2002, Ageing and apoptosis, Mech Ageing Dev, 123, 245, 10.1016/S0047-6374(01)00349-9 · DOI · Paper page
- Lessel, 2017, Dysfunction of the MDM2/p53 axis is linked to premature aging, J Clin Invest, 127, 3598, 10.1172/JCI92171 · DOI · Paper page
- Kung, 2016, The P72R polymorphism of p53 predisposes to obesity and metabolic dysfunction, Cell Reports, 14, 2413, 10.1016/j.celrep.2016.02.037 · DOI · Paper page
- Gaulton, 2008, Comprehensive association study of type 2 diabetes and related quantitative traits with 222 candidate genes, Diabetes, 57, 3136, 10.2337/db07-1731 · DOI
- Minamino, 2009, A crucial role for adipose tissue p53 in the regulation of insulin resistance, Nat Med, 15, 1082, 10.1038/nm.2014 · DOI · Paper page
- Yahagi, 2003, p53 Activation in adipocytes of obese mice, J Biol Chem, 278, 25395, 10.1074/jbc.M302364200 · DOI · Paper page
- Coppé, 2010, The senescence-associated secretory phenotype: the dark side of tumor suppression, Annu Rev Pathol, 5, 99, 10.1146/annurev-pathol-121808-102144 · DOI · Paper page
- Gustafson, 2006, Cytokines promote Wnt signaling and inflammation and impair the normal differentiation and lipid accumulation in 3T3-L1 preadipocytes, J Biol Chem, 281, 9507, 10.1074/jbc.M512077200 · DOI · Paper page
- Reis, 2016, Fat-specific Dicer deficiency accelerates aging and mitigates several effects of dietary restriction in mice, Aging (Albany NY), 8, 1201
- Gautheron, 2016, The necroptosis-inducing kinase RIPK3 dampens adipose tissue inflammation and glucose intolerance, Nat Commun, 7, 11869, 10.1038/ncomms11869 · DOI · Paper page
- Sakaguchi, 2017, Adipocyte dynamics and reversible metabolic syndrome in mice with an inducible adipocyte-specific deletion of the insulin receptor, Cell Metab, 25, 448, 10.1016/j.cmet.2016.12.008 · DOI · Paper page
- Hallenborg, 2012, Mdm2 controls CREB-dependent transactivation and initiation of adipocyte differentiation, Cell Death Differ, 19, 1381, 10.1038/cdd.2012.15 · DOI
- Hallenborg, 2016, MDM2 facilitates adipocyte differentiation through CRTC-mediated activation of STAT3, Cell Death Dis, 7, e2289, 10.1038/cddis.2016.188 · DOI
- Vergoni, 2016, DNA damage and the activation of the p53 pathway mediate alterations in metabolic and secretory functions of adipocytes, Diabetes, 65, 3062, 10.2337/db16-0014 · DOI · Paper page
Cited by
SenNet recommendations for detecting senescent cells in different tissues
Suryadevara, V., Hudgins, A. D., Rajesh, A., Pappalardo, A., Karpova, A., Dey, A. K., Hertzel, A., Agudelo, A., Rocha, A., Soygur, B., et al. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00738-8 · Cited by 408
Obesity and hyperinsulinemia drive adipocytes to activate a cell cycle program and senesce
Li, Q., Hagberg, C. E., Silva Cascales, H., Lang, S., Hyvönen, M. T., Salehzadeh, F., Chen, P., Alexandersson, I., Terezaki, E., Harms, M. J., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01501-8 · Cited by 178
Kimura, M., Suzuki, S., Moriya, A., Nogami, K., Uchida, R., Saito, Y., & Saito, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010264 · Cited by 11
“[12] showed that the knockout of MDM2, the upstream inhibitor of p53, in white adipose tissue led to metabolic disorders, including type 2 diabetes.”
Background
Metadata
- Authors
- Liu, Z., Jin, L., Yang, J.-K., Wang, B., Wu, K. K. L., Hallenborg, P., Xu, A., & Cheng, K. K. Y.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2018-08-21
- Volume
- 67
- Issue
- 11
- Pages
- 2397-2409
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2888731590
- Cited by
- 52
- References
- 15
- FWCI
- 2.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.